The Prostate · 2011 · 73 citations · 43 references
These data demonstrate that sanguinarine is a potent Stat3 inhibitor and it could be developed as a therapeutic agent for prostate cancer with constitutive activation of Stat3.
43
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Naftaly Meydan, T Grunberger, Harjit Dadi et al. · Nature · 1996 · 910 citations
Hematological Malignancy, Malignant Blood Disorder, Immunology +4
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Zhenglong Yuan, Yingjie Guan, Devasis Chatterjee et al. · Science · 2005 · 765 citations